SupportLoginSign Up
Featured FeedJournalsCollectionsKeywordsSaved Papers
Add like
Add dislike
Add to saved papers

Clinicians vs. epidemiologists: Patch testing with methyldibromo glutaronitrile as a controversial issue.

A Schnuch, S Schubert, J Geier
Journal of the European Academy of Dermatology and Venereology : JEADV 2019 Februrary 16
The preservative methyldibromo glutaronitrile (MDBGN) (CAS 35691-65-7) is known since long as an important contact allergen mainly used in cosmetics (Review: [1]). MDBGN was banned EU-wide from being used in leave-on products in 2005, for rinse-off products in 2008, and further restricted for non-cosmetic (technical) applications in 2010. However, positive reactions in patch testing (PT) continued to occur. This article is protected by copyright. All rights reserved.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.
Show additional links to paperHide additional links to paper
PubMed

Add to Saved Papers

Get 1-tap access

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app